Paul Hudson, Sanofi CEO (Jeremy Paoloni/Abaca/Sipa USA/Sipa via AP Images)
January 9, 2024 06:13 PM EST
Pharma

Paul Hud­son is 'open-mind­ed' to M&A as he plots Sanofi's trans­for­ma­tion: #JPM24

Nicole DeFeudis

Editor

SAN FRAN­CIS­CO — Sanofi CEO Paul Hud­son re­it­er­at­ed his am­bi­tions for the “new” Sanofi, in­clud­ing busi­ness de­vel­op­ment plans ahead of what some ex­perts pre­dict will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times